Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
HONG KONG, Aug 20, 2025 – (ACN Newswire via SeaPRwire.com) – In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies, product upgrades, and technological innovation, the vaccine industry maintained a stable and positive growth momentum. As a leading enterprise in China’s innovative vaccine sector, CanSino […]



















